2023 International Congress » Neuropharmacology

Meeting: 2023 International Congress

Characterisation of the pharmacokinetic profile of L-DOPA in the common marmoset

D. Bédard, F. Gaudette, F. Beaudry, P. Huot (Montreal, Canada)

Demographic, clinical and genetic factors affecting amantadine response among patients with Parkinson disease

J. Yu, L. Saadatpour, H. Kaur, I. Mata, H. Fernandez (Cleveland, USA)

Effect of ADX-88178, a highly-selective mGlu4 PAM, on parkinsonism, dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmoset

I. Frouni, C. Kwan, D. Bédard, W. Kang, S. Nuara, J. Gourdon, P. Huot (Montreal, Canada)

Effect of the 5-HT2A/2C inverse agonist nelotanserin on dyskinesia in the MPTP-lesioned marmoset

C. Kwan, I. Frouni, D. Bédard, S. Nuara, J. Gourdon, P. Huot (Montreal, Canada)

Increased alpha power in basal ganglia and thalamus following levodopa administration in a dystonic young adult

J. Nataraj, J. Maclean, SA. Seyyed Mousavi, J. Olaya, M. Liker, T. Sanger (Irvine, USA)

Motor function in Parkinson´s disease during 16h treatment with intravenously (DIZ101), subcutaneously (DIZ102), or intestinally (LCIG) infused levodopa

F. Bergquist, M. Ehrnebo, D. Nyholm, A. Johansson, F. Lundin, P. Odin, P. Svenningsson, N. Dizdar, E. Eriksson (Gothenburg, Sweden)

Neuroprotective properties of arylpiperazine-sulphonamides in an in vitro model of Parkinson’s disease

A. Kingslake, V. Soskic, M. Iravani (Hatfield, United Kingdom)

Polyaromatic hydrocarbons in Ambient Particulate Matter (PM 2.5) mediate neurodegeneration through the olfactory-brain axis in C57BL/6 mice

SR. Panda, VGM. Naidu (Guwahati, India)

Quantitative investigation of the pathway between dopamine receptors and Ca2+ channels in layer II stellate cells towards Parkinson’s disease

C. Mahapatra, A. Pradhan (MUMBAI, India)

Quetiapine for the treatment of psychosis in dementia with Lewy bodies: a systematic review.

M. Giusti, PL. Silva, G. Bolner, C. Menegon, MF. Felippe, G. Herwig, A. Rossato, EG. Almeida, M. Rosa, CR. Rieder (Porto Alegre, Brazil)

The neuroprotective properties of NLX-112 in MPTP treated mice are mediated by reactive gliosis and astrocytic GDNF

W. Powell, A. Newman-Tancredi, L. Annett, R. Depoortere, M. Iravani (Hatfield, United Kingdom)

« View all sessions from the 2023 International Congress.